Lazard Asset Management LLC raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 152.7% during the first quarter, HoldingsChannel reports. The fund owned 417,671 shares of the company’s stock after acquiring an additional 252,402 shares during the quarter. Lazard Asset Management LLC’s holdings in Cardinal Health were worth $88,258,000 as of its most recent SEC filing.
Several other hedge funds also recently added to or reduced their stakes in the stock. HF Advisory Group LLC raised its stake in shares of Cardinal Health by 0.9% in the 4th quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock valued at $1,074,000 after purchasing an additional 49 shares in the last quarter. Kathmere Capital Management LLC grew its stake in Cardinal Health by 1.2% in the first quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock worth $896,000 after purchasing an additional 49 shares in the last quarter. Hillsdale Investment Management Inc. increased its holdings in Cardinal Health by 0.9% in the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock valued at $1,184,000 after buying an additional 50 shares during the last quarter. V Square Quantitative Management LLC increased its holdings in Cardinal Health by 2.6% in the first quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock valued at $423,000 after buying an additional 50 shares during the last quarter. Finally, Generali Asset Management SPA SGR raised its stake in Cardinal Health by 11.0% during the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after buying an additional 51 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research analysts have commented on the company. Mizuho increased their target price on Cardinal Health from $235.00 to $240.00 and gave the stock an “outperform” rating in a report on Thursday, July 23rd. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. Robert W. Baird set a $248.00 price target on Cardinal Health in a research report on Friday, May 1st. UBS Group raised their price objective on Cardinal Health from $260.00 to $274.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. Finally, William Blair assumed coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating for the company. Fifteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $251.73.
Cardinal Health Stock Up 0.6%
Shares of CAH stock opened at $229.29 on Tuesday. The company has a market cap of $53.70 billion, a P/E ratio of 35.06, a PEG ratio of 1.11 and a beta of 0.49. The business has a 50 day moving average of $220.57 and a two-hundred day moving average of $214.64. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $243.21.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts expect that Cardinal Health, Inc. will post 10.77 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were given a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend was Wednesday, July 1st. Cardinal Health’s dividend payout ratio is 31.50%.
Cardinal Health Company Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Further Reading
- Five stocks we like better than Cardinal Health
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
